NFE2L2 and ischemic stroke: In this context, although Nrf2 has been pointed as a therapeutic target for human chronic diseases [74], it seems that the translation of the beneficial effects of Nrf2 activators, observed in preclinical models, into clinical sceneries of ischemic stroke (an acute condition) is less probable.